S

Sarepta Therapeutics

SRPT

144.000
USD
1.65
(1.16%)
Market Open
Volume
637
EPS
0
Div Yield
0
P/E
170
Market Cap
12,186,863,822
Related Instruments
A
ABEO
-0.10000
(-2.04%)
4.80000 USD
A
ALNY
31.19
(13.13%)
268.66 USD
B
BIIB
-2.500
(-1.17%)
210.710 USD
F
FOLD
-0.140
(-1.36%)
10.180 USD
I
IONS
1.830
(3.70%)
51.330 USD
P
PRQR
-0.10000
(-5.24%)
1.81000 USD
P
PTCT
-1.190
(-3.51%)
32.710 USD
Q
QURE
-0.14500
(-1.89%)
7.51000 USD
R
RARE
-0.870
(-1.93%)
44.140 USD
REGN
13.14
(1.22%)
1,091.19 USD
S
SAGE
-1.21000
(-11.03%)
9.76000 USD
News

Title: Sarepta Therapeutics

Sector: Healthcare
Industry: Biotechnology
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's strategy involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Most of company's product candidates are at an early stage of development.